Antagonistic selective binding agents of osteoprotegerin binding protein
Details for Australian Patent Application No. 2001238680 (hide)
International Classifications
Event Publications
22 February 2007 Application Accepted
Published as AU-B-2001238680
21 June 2007 Standard Patent Sealed
23 December 2010 Extension of Term of Standard Patents
Amgen Inc. The earliest first regulatory approval date provided by the patentee 07 Jun 2010 For the goods PROLIA denosumab
20 January 2011 Extension of Term of Standard Patents
Amgen Inc. The earliest first regulatory approval date provided by the patentee 07 Jun 2010 For the goods PROLIA denosumab Address for service in Australia: Shelston IP 60 Margaret Street Sydney NSW 2000
16 June 2011 Extension granted
Amgen Inc. The earliest first regulatory approval date provided by the patentee 07 Jun 2010 For the goods PROLIA denosumab Extension of Term of patent pursuant to Section 77 expires on 07 Jun 2025
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser